The stock of Monsanto Company (NYSE:MON) is a huge mover today! About 1.54M shares traded hands. Monsanto Company (NYSE:MON) has risen 12.74% since March 11, 2016 and is uptrending. It has outperformed by 7.29% the S&P500.
The move comes after 8 months negative chart setup for the $44.73 billion company. It was reported on Oct, 14 by Barchart.com. We have $93.84 PT which if reached, will make NYSE:MON worth $3.58B less.
Monsanto Company (NYSE:MON) Ratings Coverage
Out of 20 analysts covering Monsanto Company (NYSE:MON), 14 rate it a “Buy”, 1 “Sell”, while 5 “Hold”. This means 70% are positive. Monsanto Company has been the topic of 39 analyst reports since August 25, 2015 according to StockzIntelligence Inc. The firm earned “Buy” rating on Tuesday, June 14 by UBS. The rating was maintained by Citigroup on Friday, July 1 with “Neutral”. Goldman Sachs upgraded the stock to “Neutral” rating in Tuesday, September 27 report. As per Tuesday, August 25, the company rating was maintained by Canaccord Genuity. As per Thursday, April 7, the company rating was maintained by Citigroup. The company was upgraded on Wednesday, May 25 by Jefferies. The rating was maintained by Deutsche Bank on Thursday, October 8 with “Buy”. Canaccord Genuity maintained Monsanto Company (NYSE:MON) rating on Thursday, August 27. Canaccord Genuity has “Buy” rating and $126 price target. The company was downgraded on Thursday, September 15 by CLSA. The rating was maintained by Piper Jaffray on Thursday, August 27 with “Overweight”.
According to Zacks Investment Research, “Monsanto is a leading global provider of technology-based solutions and agricultural products for growers and downstream customers, such as grain processors and consumers, in the agricultural markets. The combination of its herbicides, seeds and related genetic trait products provides growers with integrated solutions to more efficiently and cost effectively produce crops at higher yields, while controlling weeds, insects and diseases. Its base business, led by Roundup and coupled with the latest tools in biotechnology, genomics and molecular breeding.”
Insitutional Activity: The institutional sentiment increased to 0.91 in 2016 Q2. Its up 0.10, from 0.81 in 2016Q1. The ratio is positive, as 88 funds sold all Monsanto Company shares owned while 334 reduced positions. 142 funds bought stakes while 243 increased positions. They now own 338.57 million shares or 4.89% less from 355.97 million shares in 2016Q1.
Schooner Investment Group Lc holds 500 shares or 0.12% of its portfolio. First Quadrant Ltd Partnership Ca, a California-based fund reported 2,000 shares. The Vermont-based Manchester Cap Mgmt Limited Liability Com has invested 0% in Monsanto Company (NYSE:MON). Capital Interest Investors last reported 8.19 million shares in the company. Raymond James Trust Na, a Florida-based fund reported 5,472 shares. Manning And Napier Advisors Limited Liability Corp holds 4.41 million shares or 2.77% of its portfolio. State Board Of Administration Of Florida Retirement System last reported 0.22% of its portfolio in the stock. Sandy Spring Retail Bank accumulated 0.27% or 23,079 shares. Bahl And Gaynor Inc last reported 0.02% of its portfolio in the stock. Moreover, Principal Fin Grp has 0.1% invested in Monsanto Company (NYSE:MON) for 718,743 shares. Supplemental Annuity Collective Trust Of Nj holds 7,978 shares or 0.41% of its portfolio. Gamco Investors Incorporated Et Al accumulated 0.02% or 32,250 shares. Putnam Invests last reported 865,556 shares in the company. Hemenway Limited Liability Co holds 0.06% of its portfolio in Monsanto Company (NYSE:MON) for 2,055 shares. Lazard Asset Limited holds 857,265 shares or 0.2% of its portfolio.
Insider Transactions: Since April 19, 2016, the stock had 1 buying transaction, and 2 selling transactions for $224,933 net activity. On Tuesday, April 19 POSTE GEORGE sold $104,428 worth of the stock or 1,136 shares. Another trade for 310 shares valued at $31,958 was sold by MIZELL STEVEN. MCMILLAN CHARLES S bought 3,500 shares worth $361,319.
More recent Monsanto Company (NYSE:MON) news were published by: Investorplace.com which released: “Monsanto Company’s Headwinds Make MON Stock a Tough Buy” on October 11, 2016. Also Stltoday.com published the news titled: “Monsanto’s smaller rivals see big opportunity as big companies combine” on October 12, 2016. Businesswire.com‘s news article titled: “Monsanto Company Sets Webcast and Analyst/Media Call for Fourth Quarter and …” with publication date: September 28, 2016 was also an interesting one.
MON Company Profile
Monsanto Company (Monsanto), incorporated on February 9, 2000, along with its subsidiaries, is a well-known provider of agricultural products for farmers. The Firm provides seeds, biotechnology trait products, herbicides and precision agriculture tools to farmers. The Firm operates through two divisions: Seeds and Genomics, and Agricultural Productivity.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.